FEDERAL COURT OF AUSTRALIA
Apotex Pty Ltd v Les Laboratoires Servier (No 4) [2010] FCA 1202
Citation: Apotex Pty Ltd v Les Laboratoires Servier (No 4) [2010] FCA 1202 Parties: APOTEX PTY LTD (ACN 096 916 148) v LES LABORATOIRES SERVIER, SERVIER LABORATORIES (AUST) PTY LTD
(ACN 004 838 500), SYMBION PHARMACY SERVICES PTY LTD (ACN 000 875 034),
CHEM MART PTY LIMITED (ACN 001 235 374), PHARMACOR LIMITED (ACN 121 020 835), ASCENT PHARMACEUTICALS LIMITED (ARBN 003 854 626) and SIGMA PHARMACEUTICALS (AUSTRALIA) PTY LTD (ACN 004 118 594)File number(s): NSD 657 of 2008 Judge: BENNETT J Date of judgment: 5 November 2010 Catchwords: PATENTS – overseas manufacturer of active ingredient of allegedly infringing product – provision of data for Therapeutic Goods Act 1989 (Cth) approval – companies in same corporate group – whether authorisation of infringement – whether joint tortfeasorship or common design within Australia
PRACTICE AND PROCEDURE – application to join alleged patent infringement – joinder sought of related overseas company – test for O 6 r 8 joinder – relevance of discovery motive in seeking joinder – whether reasonable cause of action under authorisation or joint tortfeasorship – whether causes of action able to withstand Federal Court of Australia Act 1976 (Cth) s 31A summary dismissal application – whether O 6 r 8 grounds satisfied – discretion to order joinder
Legislation: Federal Court of Australia Act 1976 (Cth) s 31A
Federal Court Rules O 6 r 2, O 6 r 8
Patents Act 1990 (Cth) s 13Cases cited: Adelaide Corporation v Australasian Performing Rights Association Limited (1928) 40 CLR 481 cited
Agar v Hyde (2000) 201 CLR 552 cited
Australasian Performing Right Association Ltd v Metro on George Pty Ltd (2004) 61 IPR 575 citedAustralian Tape Manufacturers Association Ltd v The Commonwealth (1993) 176 CLR 480) cited
Batistatos v Roads and Traffic Authority (NSW) (2006) 226 CLR 256 cited
Bristol-Myers Squibb Company v F H Faulding (2000) FCA 316 citedCaboolture Park Shopping Centre Pty Ltd v White Industries (QLD) Pty Ltd (unreported, Federal Court of Australia, Ryan J, 25 May 1988) discussed
Caterpillar Inc v John Deere Ltd and Others [1999] FCA 1503 distinguished
Commonwealth Bank of Australia v Peto (No 2) (2006) 152 FCR 362 followedInverness Medical Switzerland GmbH v MDS Diagnostics Pty Limited [2010] FCA 108 cited
Mead Corporation v Riverwood Multiple Packaging [1997] FSR 484 approved
Molnlycke AB v Procter & Gamble Ltd [1992] RPC 21 approvedMorton-Norwich Products Inc v Intercen Ltd [1978] RPC 501 discussed
Nationwide News Pty Ltd v Copyright Agency Ltd [1996] 65 FCR 399 cited
Spencer v Commonwealth (2010) 269 ALR 233 applied
Spotless Group Ltd v Proplast Pty Ltd (1987) 10 IPR 668 citedThree Rivers District Council v Governor and Company of the Bank of England (No 3) [2003] 2 AC 1 cited
Unilever Plc v Chefaro Proprietaries Ltd [1994] FSR 135 approvedUnilever Plc v Gillette (UK) Ltd [1989] RPC 583 approved
Universal Music Australia Pty Ltd and Others…
Keep reading for free
Create a free CaseChat account to read Apotex Pty Ltd v Les Laboratoires Servier (No 4) and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2010] FCA 1202
- Decision Date
CaseChat Overview and Summary
The primary legal issues before the court were whether Pharmaciem could be joined as a party to the proceedings under Order 6 Rule 8 of the Federal Court Rules, and whether there was a reasonable prospect that Servier's claims against Pharmaciem would succeed. The court also needed to consider whether Servier's claims against Pharmaciem could withstand a summary dismissal application under section 31A of the Federal Court of Australia Act 1976.
The court held that the discovery motive, while significant, did not preclude the joinder of Pharmaciem if Servier had a reasonable cause of action against it. The court noted that even if discovery was a primary motive for the application, it did not mean that Servier could not have a legitimate claim against Pharmaciem. The court further found that authorisation of the infringing acts by Pharmaciem required more than mere inactivity or failure to prevent the infringement, and that it was a question of fact in each case. The court concluded that there was no evidence to suggest that Pharmaciem had authorised the infringing acts of Apotex.
Ultimately, the court denied the application to join Pharmaciem as a party in the proceedings, finding that there was no reasonable prospect that Servier's claims against Pharmaciem would succeed. The court ordered that the proceedings be stood over and that the parties submit proposed orders, including orders as to costs, by a specified date. The reasons for the decision were to be kept confidential until further order.
Orders
Orders of the court
1. The parties submit proposed orders, including orders as to costs, by 10 November 2010 to give effect to these reasons.
2. The proceedings be stood over to 12 November 2010 at 9.30 am.
3. These reasons are to be kept confidential in accordance with existing confidentiality undertakings in the proceedings until further order.
Note:
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Full text does not contain this section.
Ratio Decidendi
Legal Principle Established
Servier has not challenged that undertaking.CONSIDERATIONRelevance of a Discovery Motive It was suggested in Caboolture that one reason for the application to join additional respondents was to make them compellable to give discovery. Justice Ryan said that he was not aware of any authority suggesting that joinder is available for that purpose, which appeared to be ulterior to that contemplated by O 6 r 8 of the FCR. As in Caboolture, the role of Pharmacem has been known for some time and there is no explanation as to why Servier has resiled from its initial decision not to join Pharmacem at the outset. However, Servier denies that discovery is the sole purpose of its application to join Pharmacem. If the Court is not satisfied that there is no reasonable prospect of Servier succeeding in its case against Pharmacem, several United Kingdom cases indicate that, even if a primary motive for the joinder is the obtaining of discovery from Pharmacem, this does not preclude the joinder of Pharmacem (Molnlycke AB v Procter & Gamble Ltd [1992] RPC 21; Gillette; Unilever Plc v Chefaro Proprietaries Ltd [1994] FSR 135 (Chefaro)). I agree, however, with what was said by Lord Hoffmann in Chefaro at 142-3, which, despite differences in the test for summary dismissal in that case, is apposite:In practice, however, the plaintiff has no interest in obtaining a final judgment against the additional defendant. The remedy against the primary infringer would usually be adequate. The plaintiff will have achieved the whole of its objective by keeping the additional defendant in the action for the purposes of discovery. It therefore seems strange to me that its right to do so should depend upon whether the court thinks there is a serious issue to be tried on a question which thereafter no-one will seriously want to have tried at all… The logical solution, as it seems to me, is that discovery of research and development documents should be available against a multi-national on a group basis… This would, however, require legislative change which the responsible authorities may wish to consider. The fact that discovery is a motive, even a primary motive for the application, does not preclude joinder if Servier has a reasonable cause of action against Pharmacem.Authorisation Servier relies on authorisation by Pharmacem of the infringing acts of Apotex. Mere inactivity or failure to take some steps to prevent an infringing act does not necessarily establish authorisation (Adelaide Corporation v Australasian Performing Rights Association Limited (1928) 40 CLR 481 at 504). It is a question of fact in each case what is the true inference to be drawn. In Moorhouse (1975) 133 CLR 1, Gibbs J (at [13]) considered to be ‘too widely expressed’ the observation of Isaac J in dissent in Adelaide that infringement would lie where a person knew or had reason to know that a particular infringing act would be performed and having the legal power to prevent it nevertheless disregards that power and allows the act to be done.